DAFALGAN Dolo cpr eff 500 mg 16 pce

7680692650016 CH-69265 N02BE01 01.01.1.
DAFALGAN Dolo cpr eff 500 mg 16 pce
DAFALGAN Dolo cpr eff 500 mg 16 pce
DAFALGAN Dolo cpr eff 500 mg 16 pce
1 / 3
google

Details

Product number
6926501
CPT
-
Packaging group
16
Unit
Tablette(n)
Composition
paracetamolum 500 mg, acidum citricum, natrii hydrogenocarbonas, natrii carbonas, natrii docusas, povidonum K 30, sorbitolum 300 mg, saccharinum natricum, E 211 60.606 mg, pro compresso corresp. natrium 412.3 mg.

Articles (1)

Dafalgan DOLO 500 mg, Brausetabletten
Brausetabletten
16
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
17/06/2025
Patient information leaflet
Français
17/06/2025
Patient information leaflet
Italien
17/06/2025
Professional SmPC
Allemand
17/06/2025
Professional SmPC
Français
17/06/2025
Professional SmPC
Italien
17/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
500.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
126.1 MG Substance HBESI
(N/A)
50.0 MG Substance HBESI
(N/A)
- Substance AROMA
(N/A)
0.83 MG Substance HBESI
(N/A)
0.96 MG Substance HBESI
(N/A)
0.28 MG Substance HBESI
(N/A)
- Substance HIMDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
197.0 MG Substance HBESI

Authorization holder

UPSA Switzerland AG

6300 Zug

Authorization information

Swissmedic authorization number
69265
Drug name
Dafalgan DOLO, Brausetabletten
Galenic form
BRAT
ATC Code
N02BE01
Authorization status
Z
Dispensation category
D
First authorization
01/05/2024
Authorization expiration date
30/04/2029
IT number
01.01.1.
Domain
Human medicine
Field of application
Analgetikum, Antipyretikum

Packaging details

Description (FR)
DAFALGAN Dolo cpr eff 500 mg 16 pce
Description (DE)
DAFALGAN Dolo Brausetabl 500 mg 16 Stk
Market launch
01/05/2024
Narcotic (BTM)
No